Jigar Shah

Dr. Jigar Shah, M.D.

Dr. Shah is board certified in Internal Medicine and Rheumatology. He completed his Bachelor of Science at the University Of Miami, Coral Gables, FL. He graduated from St George’s University School Of Medicine, St. George’s, Grenada, and completed his Rheumatology fellowship at SUNY Downstate University Medical Center in Brooklyn, NY. He has been a Sub-investigator on multiple Rheumatology clinical trials while in NY and currently serves as a Sub-Investigator in the clinical research department.


SUNY Downstate University Medical Center in Brooklyn, NY 7/2013 – 7/2015

  • Rheumatology Fellow
  • Responsibilities include:
    • Active coverage of inpatient rheumatology consultations
    • Performing procedures such as joint aspiration and musculoskeletal injections
    • Evaluating and enrolling patients into clinical trials of new therapeutic agents, especially for SLE
    • Placing infusion orders for biologic agents in the outpatient chemotherapy unit and for clinical trial patients
    • Training in Musculoskeletal Ultrasound at the VA campus with US Sonosite

SUNY Downstate University of Brooklyn at Long Island College Hospital 6/2009 – 6/2012

  • Internal Medicine

St. George’s University School of Medicine, St. George’s, Grenada 8/2005 – 6/2009
University of Miami, Coral Gables, Florida 8/2001 – 5/2005

  • Bachelor of Science – Majors in Biology and Psychology with Minor in Chemistry

Licensure and Certifications:

Board Certified in Internal Medicine and Rheumatology
Active Florida License and DEA
ACLS/BLS Certified 2015

Naturalization Status:

United States Citizen

  • Born in Palm Beach Gardens, FL on November 11, 1983

Research Experience / Abstracts:

AARDS Research, Inc.

  • Sub-Investigator at 21097 NE 27th Court, Suite 200, Aventura, FL 33180 2015 – Present
  • Performing physical examinations, joint assessments, PsA assessments, and disease activity assessments associated with rheumatic diseases

Descriptive Review of Knee Osteoarthritis in Systemic Lupus Erythematous Patients 2015

  • Co-principal Investigator

Sub investigator: Department of Rheumatology, SUNY Downstate Medical Center 2013 – 2015

  • GSK/HGS: A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race with Systemic Lupus Erythematosus (SLE) (Protocol #HGS 1006-C1112 / GSK BEL 115471)
  • GSK/HGS: A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab plus Standard of Care versus Placebo Plus Standard of Care in Adult Subjects with Active Lupus Nephritis (Protocol # HGS 1006-C1121 / GSK BEL 114054)
  • GSK / HGS: A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Systemic Lupus Erythematosus (SLE)) Protocol # HGS 1006-C1115 / GSK BEL 112341)
  • GSK / HGS: A Multi-Center, Open-Label Continuation Trial of LymphoStat-B Antibody (Monoclonal Anti-BlyS Antibody) in Subjects with Systemic Lupus Erythematosus (SLE) Who Completed the Phase 2 Protocol LBSL02 (Protocol #LBSL99)
  • GSK / HGS: A Multi-Center Continuation Trial of Belimumab (HGS 1006, LymphoStat-B) a Fully Human Monoclonal Anti-BlyS Antibody in Subjects with Systemic Lupus Erythematosus (SLE) Who Completed Phase 3 Protocol HGS 1006-C1056 in the United States (Human Genome Sciences, Inc. HGS1006-C1066)
  • BMS: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 (Abatacept) or Placebo on a Background of Mycophenolate Mofetil (MMF) and Corticosteroids in Subjects with Active Class III Lupus Nephritis (Protocol #IM101-291)
  • Takeda Development Center Americas Inc.: A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects with ISN / RPS Class III or IV Lupus Nephritis. Protocol Number: MLN9708_101
  • Aurinia Pharmaceuticals Inc.: Phase II A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) with Placebo in Achieving Remission in Patients with Active Lupus Nephritis. Protocol #AUR-VCS-2012-01
  • Lupus Clinical Trials Consortium, Inc.: A Prospective Registry to Study Presentation, Clinical Course, Treatment Patterns, and Outcomes in Patients with Systemic Lupus Erythematosus

American Thoracic Society Abstract: Extra – Meningeal Manifestations Of Fulminant Meningococcemia: An Intensivist Perspective
American Thoracic Society Abstract: Propylene Glycol Intoxication Without An Anion Gap metabolic Acidosis
Comparative effectiveness and time to response among adalimumab, abtacept, entanercept, and infliximab for the treatment of rheumatoid arthritis in a real world routine case registry. 2010 – 2011

  • Research Assistant – working directly with Dr. Yusuf Yazici (NYU-Joint Disease)

ACP NY Abstract: Invasive Mucinous Carcinoma in a Male Breast 2011
University of Miami – Behavioral Medicine Research Center 2003 – 2005

  • Research Assistant – Positive Survivors Research Study – examined how stress affects the health and immunity of people living with HIV.

Work Experience:

Arthritis and Rheumatic Disease Specialties Medical Center 2015 – Present

  • Rheumatologist

Coral Springs Medical Center 2012 – 2015

  • Hospitalist with Sound Physicians

University of Miami – College of Arts and Sciences 2003 – 2005

  • Biology Peer Advisor – Provided guidance to incoming freshman students; worked as a direct liaison between students and faculty.

Extracurricular Activities / Leadership Roles:

American College of Rheumatology Member 2012 – Present
Brooklyn VA Hospital: Mini-MSK Residency Teaching assistant 2015

  • Assisted in teaching musculoskeletal exams to other specialties including primary care, geriatrics, and physical therapy.

Biology Workshop Leader 20014 – 2005

  • Mentored students in addition to teaching them Biology

‘Canes Chess Club Co-founder and President 2003 – 2004

  • Organized chess club meetings and interactive tournaments.

United States Presidential Debate Volunteer Committee 2004

  • Assisted in coordinating various events leading up to the Presidential Debate and during the Debate at the University of Miami

Quality Improvement Projects:

Influenza Vaccine Rate in Rheumatology Patients 2015
Hospital Re-admission Rates within the past 30 days 2012

Personal Interests and Hobbies:


Copyright © 2017 Arthritis & Rheumatic Disease Specialties | Nondiscrimination | Privacy Practices | Limited English Assistance Services